David M Dill Net Worth

The estimated Net Worth of David M Dill is at least $72.7 ezer dollars as of 21 May 2022. David Dill owns over 5,151 units of R1 RCM stock worth over $72,732 and over the last 9 years David sold RCM stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

David Dill RCM stock SEC Form 4 insiders trading

David has made over 7 trades of the R1 RCM stock since 2016, according to the Form 4 filled with the SEC. Most recently David exercised 5,151 units of RCM stock worth $72,732 on 21 May 2022.

The largest trade David's ever made was exercising 50,000 units of R1 RCM stock on 19 February 2016 worth over $706,000. On average, David trades about 12,385 units every 163 days since 2016. As of 21 May 2022 David still owns at least 5,151 units of R1 RCM stock.

You can see the complete history of David Dill stock trades at the bottom of the page.

What's David Dill's mailing address?

David's mailing address filed with the SEC is C/O R1 RCM INC., 433 W. ASCENSION WAY, SUITE 200, MURRAY, UT, 84123.

Insiders trading at R1 RCM

Over the last 7 years, insiders at R1 RCM have traded over $770,079,900 worth of R1 RCM stock and bought 103,238 units worth $1,376,421 . The most active insiders traders include Achi Series Lllptcp Asc Gp,..., Joseph Gerard Flanagan és John B Iii Henneman. On average, R1 RCM executives and independent directors trade stock every 27 days with the average trade being worth of $7,812,780. The most recent stock trade was executed by John M. Sparby on 6 March 2024, trading 10,046 units of RCM stock currently worth $143,959.

What does R1 RCM do?

R1 RCM Inc. is an American revenue cycle management company servicing hospitals, health systems and physician groups across the United States.

Complete history of David Dill stock trades at R1 RCM

R1 RCM executives and stock owners

R1 RCM executives and other stock owners filed with the SEC include:

• Joseph Flanagan,
  President, Chief Executive Officer, Director
• Gary Long,
  Executive Vice President, Chief Commercial Officer
• Joseph Gerard Flanagan,
  Pres, CEO & Director
• Gary S. Long,
  Exec. VP & Chief Commercial Officer
• Richard Evans,
  Senior Vice President, Chief Accounting Officer, Corporate Controller
• Richard B. Evans Jr.,
  Sr. VP, Corp. Controller & Chief Accounting Officer
• Rachel Wilson,
  Exec. VP, CFO & Treasurer
• Alex Mandl,
  Lead Independent Director
• Michael Feiner,
  Independent Director
• Jill Smith,
  Independent Director
• John Henneman,
  Independent Director
• Anthony Tersigni,
  Director
• Anthony Speranzo,
  Independent Director
• Rachel Wilson,
  Chief Financial Officer, Treasurer
• Atif Rahim,
  Senior Vice President - Investor Relations & Business Development
• Vijay Kotte,
  Executive Vice President - Physician Services
• Ian Sacks,
  Independent Director
• Neal Moszkowski,
  Independent Director
• Albert Zimmerli,
  Director
• Vijay Kumar Kotte,
  Exec. VP of Strategy & Corp. Devel. and Chief Solutions Officer
• Sean Radcliffe,
  Exec. VP, Gen. Counsel & Corp. Sec.
• Corey Perman,
  Exec. VP of Compliance & Risk
• Jay Sreedharan,
  Chief Technology & Digital Officer
• John M. Sparby,
  Exec. VP of Operations & Delivery and COO
• Charles J. Ditkoff,
  Director
• Steven J Shulman,
  Director
• Christopher Simon Ricaurte,
  Chief Financial Officer
• Mountain Capital, L.L.C.Coy...,
  
• Pamela L. Spikner,
  Principal Accounting Officer
• Thomas A Lesica,
  Chief Operating Officer
• Bradford Kyle Armbrester,
  Director
• Jeremy Delinsky,
  Director
• David M Dill,
  Director
• Scanlan Agnes Bundy,
  Director
• Lee Rivas,
  Chief Executive Officer
• John M. Sparby,
  President
• Jennifer D. Williams,
  Chief Financial Officer
• Kyle Hicok,
  Chief Commercial Officer